164 related articles for article (PubMed ID: 15617740)
1. Global fibrinolytic capacity in children on dialysis.
Agras PI; Baskin E; Cengiz N; Kirazli S; Saatci U; Ozbek N
Thromb Res; 2005; 115(3):185-9. PubMed ID: 15617740
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
[TBL] [Abstract][Full Text] [Related]
3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
4. Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD.
Bertoli SV; di Belgiojoso GB; Trezzi M; Scorza D; Barone MT; Poggio M; Rossi E; Landriani N; Genderini A
Adv Perit Dial; 1995; 11():127-30. PubMed ID: 8534685
[TBL] [Abstract][Full Text] [Related]
5. Hemostasis and global fibrinolytic capacity in chronic liver disease.
Aytac S; Turkay C; Bavbek N; Kosar A
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):623-6. PubMed ID: 17890949
[TBL] [Abstract][Full Text] [Related]
6. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
[TBL] [Abstract][Full Text] [Related]
7. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
8. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic activity in multiple myeloma.
Yağci M; Sucak GT; Haznedar R
Am J Hematol; 2003 Dec; 74(4):231-7. PubMed ID: 14635202
[TBL] [Abstract][Full Text] [Related]
11. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
12. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
13. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
Borazan A; Aydemir S; Sert M; Yilmaz A
Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of serum sialic acid concentration in chronic renal failure children on continuous ambulatory peritoneal dialysis and hemodialysis].
Szprynger K; Szczepańska M; Mazur B; Dyduch A; Zwolińska D; Morawiec-Knysak A; Makulska I
Pol Merkur Lekarski; 2000 Jul; 8(49):459-61. PubMed ID: 11070713
[TBL] [Abstract][Full Text] [Related]
15. Predictors of serum albumin level in patients receiving continuous ambulatory peritoneal dialysis.
Sezer S; Ozdemir FN; Akman B; Arat Z; Anaforoglu I; Haberal M
Adv Perit Dial; 2001; 17():210-4. PubMed ID: 11510278
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
Grzegorzewska AE; Mariak I
Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296
[TBL] [Abstract][Full Text] [Related]
18. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
Alhamdani MS
Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism.
Suzuki T; Kanno Y; Nakamoto H; Okada H; Sugahara S; Suzuki H
Adv Perit Dial; 2003; 19():148-54. PubMed ID: 14763052
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in Type 1 diabetes: evidence for normal fibrinolytic state.
Harmanci A; Kandemir N; Dagdelen S; Gonc N; Buyukasik Y; Alikasifoglu A; Kirazli S; Ozon A; Gurlek A
J Diabetes Complications; 2006; 20(1):40-4. PubMed ID: 16389166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
